Skip to main content

nl
fr
en

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Veterinary medicines
Medicines
Medicines
Marketing Authorisation procedures
MRL

Medicines
- Medicines
Particular products
Health products
- Medical devices and their accessories

Maximum residue limits (MRL)

Under construction.

Last updated on 30/12/2008

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

03/12/2018

Recognition of the FAMHP by the American Food and Drug Administration (FDA)

26/11/2018

Give your opinion on a genetically modified vaccine against respiratory syncytial virus (RSV) infections

19/11/2018

Make medicines safer by reporting side effects in children or during pregnancy or breast feeding. The FAMHP again participates in an international campaign to emphasize the importance of reporting side effects.

16/11/2018

Update on the new Clinical Trial Regulation pilot project

All news

© 2016 - FAMHP

Site map
Disclaimer
Complaints
Contact